TELA today
$0.86-$0.08 (-8.69%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bearish
1 hourLeaning Bearish
15 minExpanding
5 minExpanding
Daily trend turns down below $0.60
Key levels
Resistance$1.19
Resistance$0.93
Support$0.78
Support$0.62
Latest news & SEC filings
EarningsTELA Bio Posts Q3 2026 Results
EarningsTELA Bio holds Q3 2026 earnings call
SEC FilingTELA Bio, Inc. filed a shelf registration for future offerings (Form S-3)
SEC FilingTELA Bio, Inc. filed a report on a major company event (Form 8-K)
All TELA news →About TELA Bio
TELA Bio develops and sells soft-tissue reconstruction products used in surgery. Its main products are OviTex, used to treat hernias and rebuild the abdominal wall, and OviTex PRS, used in plastic and reconstructive procedures. The company markets mainly through its own sales team in the United States, with a smaller presence in the United Kingdom and Europe, selling to surgeons and healthcare providers.
Based on the company's 10-K filed Mar 25, 2026.
Nasdaq · Healthcare
TELA Bio, Inc. (TELA)
What Is the Price Target for TELA?
SEPT Low Target
$2.00
SEPT Mid Target
$2.50
SEPT High Target
$3.00
Analyst Consensus
$2.50
Is TELA a Buy or Sell Right Now?
Thesis
- •Revenue growing 15.8% YoY with STRONG trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TELA.
Start Free Trial →Is TELA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$2.50
31
Moat Score
NONE
3/9
Piotroski Score
-6.0
Altman Z-Score
What Is Smart Money Doing with TELA?
Insider Signal
BUYING
4 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Capper Joseph H | director | Buy | 19,801 | $20K | Oct 15, 2026 |
| Capper Joseph H | director | Buy | 25,000 | $31K | Sep 17, 2026 |
| Capper Joseph H | director | Buy | 50,000 | $58K | Sep 16, 2026 |
| Capper Joseph H | director | Buy | 50,000 | $53K | Sep 15, 2026 |
| Capper Joseph H | director | Buy | 25,000 | $26K | Sep 14, 2026 |
| Rocchio Betty Jo | director | Buy | 11,675 | - | Jun 9, 2026 |
| Plovanic William J. | director | Buy | 11,675 | - | Jun 9, 2026 |
| Capper Joseph H | director | Buy | 11,925 | - | Jun 9, 2026 |
| Capper Joseph H | director | Buy | 11,675 | - | Jun 9, 2026 |
| NEELS GUIDO J | director | Buy | 11,925 | - | Jun 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TELA Growth Story
Revenue YoY
15.8%
3yr Revenue CAGR
24.7%
EPS Growth YoY
37.59%
FCF Growth YoY
32.7%
Revenue Trend
STRONG
Dark Pool Trades for TELA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TELA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:37:48 | $0.82 | 2,600 | $$2K | BUY |
| 20:28:33 | $0.79 | 3,120 | $$2K | SELL |
| 20:24:54 | $0.80 | 1,500 | $$1K | SELL |
| 20:14:54 | $0.80 | 1,300 | $$1K | SELL |
| 20:12:56 | $0.79 | 10,000 | $$8K | BUY |
5 dark pool trades shown · $$15K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for TELA Bio, Inc. (TELA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TELA — frequently asked questions
What is TELA stock price today?
TELA Bio, Inc. (TELA) is at $0.86, down 8.69% (-$0.08) at the Nov 12, 2026 close.
Why is TELA stock moving today?
Latest TELA news — Nov 11, 2026: TELA Bio Posts Q3 2026 Results · Nov 10, 2026: TELA Bio holds Q3 2026 earnings call
What is the TELA price target?
The average analyst price target for TELA is $2.50, ranging from $2 to $3, based on 2 analysts.
What do analysts rate TELA?
Analyst ratings for TELA: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did TELA beat earnings?
TELA last reported on Aug 10, 2026: EPS -$0.20 vs -$0.17 expected — a miss of 15.1%.
Does TELA pay a dividend?
TELA does not currently pay a dividend.
What are TELA support and resistance levels?
Support: $0.78, $0.62. Resistance: $0.93, $1.19, $1.50.
What are insiders doing with TELA?
Insider activity: BUYING, 4 buys and 0 sells in the last 90 days.
What is the latest news on TELA?
Nov 11, 2026: TELA Bio Posts Q3 2026 Results · Nov 10, 2026: TELA Bio holds Q3 2026 earnings call · Nov 10, 2026: TELA Bio, Inc. filed a shelf registration for future offerings (Form S-3)